podcast
details
.com
Share
Not So Different: A Podcast from The Center for Biosimilars
S6 Ep29: Biosimilars Policy Roundup for April 2024—Podcast Edition
Listen
Description
Show notes
FDA Approves Henlius’ Trastuzumab Biosimilar, Hercessi
Alvotech’s Stelara Biosimilar, Selarsdi, Receives FDA Approval
Eye on Pharma: EU Ustekinumab Approval; New Golimumab Data; Evernorth Adds Humira Biosimilar
AON Saves Over $243 Million With High Biosimilar Adoption
Julie Reed: Why 2024 Is Important for Biosimilars
The 6 Key Policy Factors to Ensure Biosimilar Market Sustainability
Biosimilars Council: PBM Rebate Schemes Cost Americans, Payers $6 Billion
Review Highlights Most Popular European Policies to Boost Biosimilar Uptake
podcast
details
Print
Share
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
Check it
This website doesn't track the visitors or use any cookies. Made by
Alex Barredo
. Send your feedback to
alex@barredo.es
.
